Diabetes Drugs Won the Weight-Loss Battle, Reshaping Weight Care: Research centers keep long waitlists to assess long-term effects,

The new diabetes-drug class used for weight loss became one of the most prescribed worldwide, opening a twin health-and-economy file.

Growing research documents effects beyond lost kilos, including heart-risk and inflammation improvements.

Supply shortages and high costs raised equality questions between rich and poor countries.

Research centers keep long waitlists to assess long-term effects, a story unfolding dose by dose.